Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reddel

Showing results (91-100 of 259) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|March 22, 2001
Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathwayT Sugihara, S C Kaul, J Kato, et al.
Nature Genetics|March 29, 2002
Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cellsHelen Varley, Hilda A Pickett, Jennifer L Foxon, et al.
Cancer Research|April 3, 2004
Alternative lengthening of telomeres is characterized by high rates of telomeric exchangeJ Arturo Londoño-Vallejo, Héra Der-Sarkissian, Lucien Cazes, et al.
Cancer Research|July 27, 2007
DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNAClare L Fasching, Axel A Neumann, Alessandra Muntoni, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|July 25, 2000
Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two allelesS C Kaul, E Duncan, T Sugihara, et al.
Scientific Reports|August 23, 2017
MatCol: a tool to measure fluorescence signal colocalisation in biological systemsMatloob Khushi, Christine E Napier, Christine M Smyth, et al.
Cancer Research|August 3, 2002
Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivoRenu Wadhwa, Lorel Colgin, Tomoko Yaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Predictive Biomarkers of Antibody-Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative ProteomicsNicholas J McNamee, Jia Liu, Rebecca C Poulos, et al.
Oncogene|June 11, 1999
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybridsK Perrem, T M Bryan, A Englezou, et al.
Neoplasia (New York, N.Y.)|February 24, 2001
The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activityL M Colgin, C Wilkinson, A Englezou, et al.
Pageof 26

Showing results (91-100 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|March 22, 2001
Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathwayT Sugihara, S C Kaul, J Kato, et al.
Nature Genetics|March 29, 2002
Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cellsHelen Varley, Hilda A Pickett, Jennifer L Foxon, et al.
Cancer Research|April 3, 2004
Alternative lengthening of telomeres is characterized by high rates of telomeric exchangeJ Arturo Londoño-Vallejo, Héra Der-Sarkissian, Lucien Cazes, et al.
Cancer Research|July 27, 2007
DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNAClare L Fasching, Axel A Neumann, Alessandra Muntoni, et al.
DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|July 25, 2000
Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two allelesS C Kaul, E Duncan, T Sugihara, et al.
Scientific Reports|August 23, 2017
MatCol: a tool to measure fluorescence signal colocalisation in biological systemsMatloob Khushi, Christine E Napier, Christine M Smyth, et al.
Cancer Research|August 3, 2002
Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivoRenu Wadhwa, Lorel Colgin, Tomoko Yaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Predictive Biomarkers of Antibody-Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative ProteomicsNicholas J McNamee, Jia Liu, Rebecca C Poulos, et al.
Oncogene|June 11, 1999
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybridsK Perrem, T M Bryan, A Englezou, et al.
Neoplasia (New York, N.Y.)|February 24, 2001
The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activityL M Colgin, C Wilkinson, A Englezou, et al.
Pageof 26